AI-DRIVEN VASCULAR RISK ANALYSIS
AINOVA identifies vascular diseases before it's too late. Optimizing treatments and reducing costs for patients and health providers.
Vascular Risk Analysis Tool
Enabling preventive care and intervention through routine scanning of risk groups
Visualized 4D patient-specific blood flow and vascular function
Comprehensive Zero-Click analysis:
Reduced downstream testing
No exposure to radiation
No nephrotoxic contrast
Collaborations & Partnerships
AINOVA is partnering with the NHS's (National Health Services of the United Kingdom) Innovation Department. This partnership serves as a reliable source of patient data, a beta-testing site, and an opportunity for clinical validation & integration.
AINOVA's US partnership is with the Department of Neurovascular Imaging Core at UCLA (University of California Los Angeles). This relationship serves as a source of neurovascular imaging, beta-testing, and as an opportunity for clinical validation.
Currently on our clinical research journey; AINOVA is providing clinical insights for the early identification of vascular diceases.